|
Volume 15 Issue 2
|
|
Comment |
|
|
It takes two to tango in the microenvironment!
Josie Ursini-Siegel, Morag Park Breast Cancer Research 2013, 15:102 (12 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Metformin: a case of divide and conquer
Dimitrios Anastasiou Breast Cancer Research 2013, 15:306 (11 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Elf5 - breast cancer's little helper
Hayley T Frend, Christine J Watson Breast Cancer Research 2013, 15:307 (27 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Closing escape routes: inhibition of IL-8 signaling enhances the anti-tumor efficacy of PI3K inhibitors
Ashish Juvekar, Gerburg M Wulf Breast Cancer Research 2013, 15:308 (8 April 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Activating mutations and senescence secretome: new insights into HER2 activation, drug sensitivity and metastatic progression
Swarnali Acharyya Breast Cancer Research 2013, 15:309 (23 April 2013)
Abstract | Full text | PDF
| PubMed
|
|
Review |
|
|
The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy
Mun Hui, Aurélie Cazet, Radhika Nair, D Watkins, Sandra A O'Toole, Alexander Swarbrick Breast Cancer Research 2013, 15:203 (28 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker
Michael L Salmans, Fang Zhao, Bogi Andersen Breast Cancer Research 2013, 15:204 (24 April 2013)
Abstract | Full text | PDF
| PubMed
|
|
Research |
|
|
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
John FR Robertson, J Michael Dixon, D Mark Sibbering, Ali Jahan, Ian O Ellis, Eddie Channon, Pauline Hyman-Taylor, Robert I Nicholson, Julia MW Gee Breast Cancer Research 2013, 15:R18 (5 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II
Renée T Fortner, A Heather Eliassen, Donna Spiegelman, Walter C Willett, Robert L Barbieri, Susan E Hankinson Breast Cancer Research 2013, 15:R19 (6 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer
Areti Strati, Sabine Kasimir-Bauer, Athina Markou, Cleo Parisi, Evi S Lianidou Breast Cancer Research 2013, 15:R20 (7 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
Hannah Harrison, Bruno M Simões, Lynsey Rogerson, Sacha J Howell, Göran Landberg, Robert B Clarke Breast Cancer Research 2013, 15:R21 (8 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer
Marc-André Déry, Julie Jodoin, Josie Ursini-Siegel, Olga Aleynikova, Cristiano Ferrario, Saima Hassan, Mark Basik, Andréa C LeBlanc Breast Cancer Research 2013, 15:R22 (12 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer
Xuedong Yin, Tingxiu Xiang, LiLi Li, Xianwei Su, Xingsheng Shu, Xinrong Luo, Jianbo Huang, Ying Yuan, Weiyan Peng, Michael Oberst, Kathleen Kelly, Guosheng Ren, Qian Tao Breast Cancer Research 2013, 15:R23 (12 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
Laurel A Habel, Lori C Sakoda, Ninah Achacoso, Xiao-Jun Ma, Mark G Erlander, Dennis C Sgroi, Louis Fehrenbacher, Deborah Greenberg, Charles P Quesenberry Breast Cancer Research 2013, 15:R24 (14 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers
Marketa Zvelebil, Erik Oliemuller, Qiong Gao, Olivia Wansbury, Alan Mackay, Howard Kendrick, Matthew J Smalley, Jorge S Reis-Filho, Beatrice A Howard Breast Cancer Research 2013, 15:R25 (18 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer
Sepideh Gholami, Chun-Hao Chen, Laurence J Belin, Emil Lou, Sho Fujisawa, Caroline Antonacci, Amanda Carew, Nanhai G Chen, Marina De Brot, Pat B Zanzonico, Aladar A Szalay, Yuman Fong Breast Cancer Research 2013, 15:R26 (18 March 2013)
Abstract | Provisional PDF
| PubMed
|
Editor’s summary
Oncolytic vaccinia virus, GLV1h-153, engineered to express the human sodium iodide symporter (hNIS) gene is useful in imaging cancers and can be used to identify and treat positive surgical margins of breast cancer in mice.
|
|
|
Risk of breast cancer in Lynch syndrome: a systematic review
Aung Win, Noralane M Lindor, Mark A Jenkins Breast Cancer Research 2013, 15:R27 (19 March 2013)
Abstract | Full text | PDF
| PubMed
|
|
|
Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer
Benjamin A Katchman, I Tolgay Ocal, Heather E Cunliffe, Yu-Hui Chang, Galen Hostetter, Aprill Watanabe, Janine LoBello, Douglas F Lake Breast Cancer Research 2013, 15:R28 (28 March 2013)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
Rita D Brandão, Jürgen Veeck, Koen K Van de Vijver, Patrick Lindsey, Bart de Vries, Catharina HMJ van Elssen, Marinus J Blok, Kristien Keymeulen, Torik Ayoubi, Hubert JM Smeets, Vivianne C Tjan-Heijnen, Pierre S Hupperets Breast Cancer Research 2013, 15:R29 (8 April 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
A randomized controlled trial finds that celecoxib, a COX-2 inhibitor, induces anti-tumor transcriptional changes in primary breast cancer tissue, suggesting a use for celecoxib in future treatments.
|
|
|
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma
Nirukshi U Samarajeewa, Fangyuan Yang, Maria M Docanto, Minako Sakurai, Keely M McNamara, Hironobu Sasano, Stephen B Fox, Evan R Simpson, Kristy A Brown Breast Cancer Research 2013, 15:R30 (8 April 2013)
Abstract | Provisional PDF
| PubMed
|
|
|
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
Alison F Munro, Annette Bartels, Eva Balslev, Christopher J Twelves, David A Cameron, Nils Brünner, John MS Bartlett Breast Cancer Research 2013, 15:R31 (9 April 2013)
Abstract | Provisional PDF
| PubMed
|
|
|
Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling
Lopamudra Roy, Jennifer M Curry, Mahnaz Sahraei, Dahlia M Besmer, Amritha Kidiyoor, Helen E Gruber, Pinku Mukherjee Breast Cancer Research 2013, 15:R32 (11 April 2013)
Abstract | Provisional PDF
| PubMed
|
Editor’s summary
A mouse model of rheumatoid arthritis shows that SCF/c-Kit signalling mast cells accumulate in bone and lung metastatic niches, which enhances breast cancer metastasis.
|
|
|
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs
Muhammad Riaz, Marijn TM van Jaarsveld, Antoinette Hollestelle, Wendy JC Prager-van der Smissen, Anouk AJ Heine, Antonius WM Boersma, Jingjing Liu, Jean Helmijr, Bahar Ozturk, Marcel Smid, Erik A Wiemer, John A Foekens, John WM Martens Breast Cancer Research 2013, 15:R33 (19 April 2013)
Abstract | Provisional PDF
| PubMed
|
|
|
Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study
Roni T Falk, Louise A Brinton, Joanne F Dorgan, Barbara J Fuhrman, Timothy D Veenstra, Xia Xu, Gretchen L Gierach Breast Cancer Research 2013, 15:R34 (22 April 2013)
Abstract | Provisional PDF
| PubMed
|
|
|
Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experience
Paul M Meaney, Peter A Kaufman, Lori S Muffly, Michael Click, Stephen P Poplack, Wendy A Wells, Gary N Schwartz, Roberta M di Florio-Alexander, Tor D Tosteson, Zhongze Li, Shireen D Geimer, Margaret W Fanning, Tian Zhou, Neil R Epstein, Keith D Paulsen Breast Cancer Research 2013, 15:R35 (24 April 2013)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Microwave imaging may provide a low cost alternative to magnetic resonance and positron emission tomography for monitoring patient response to neoadjuvant chemotherapy (NCT).
|
|
|
Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium
Fabienne Meier-Abt, Emanuela Milani, Tim Roloff, Heike Brinkhaus, Stephan Duss, Dominique S Meyer, Ina Klebba, Piotr J Balwierz, Erik van Nimwegen, Mohamed Bentires-Alj Breast Cancer Research 2013, 15:R36 (29 April 2013)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Early parity in mice alters the genomic signature of a distinct subset of mammary epithelial cells by inducing differentiation and reducing proliferation, ultimately protecting against breast cancer.
|